NasdaqCM - Delayed Quote USD
Celularity Inc. (CELU)
1.7500
-0.0100
(-0.57%)
At close: June 13 at 4:00:02 PM EDT
1.7600
+0.01
+(0.57%)
After hours: June 13 at 7:18:52 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
BEERS DAVID C Chief Financial Officer | Conversion of Exercise of derivative security | Apr 11, 2025 | 18,201 |
BERMAN RICHARD JAY Director | Stock Award(Grant) | Dec 19, 2024 | 67,416 |
BRIGIDO STEPHEN Officer | Conversion of Exercise of derivative security | Apr 11, 2025 | 8,921 |
DIAMANDIS PETER Director | Stock Award(Grant) | Dec 19, 2024 | 1,374,480 |
HAINES JOHN R. Officer | Conversion of Exercise of derivative security | Apr 11, 2025 | 29,121 |
HARIRI ROBERT J Chief Executive Officer | Conversion of Exercise of derivative security | Apr 11, 2025 | 2,851,450 |
KEHLER DEAN C Director | Stock Award(Grant) | Dec 19, 2024 | 303,482 |
LIM KOK THAY Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jan 24, 2025 | -- |
LING GEOFFREY M. D. Director | Stock Award(Grant) | Dec 19, 2024 | 67,416 |
PARKS DIANE L. Director | Stock Award(Grant) | Dec 19, 2024 | 303,482 |
Related Tickers
AARD Aardvark Therapeutics, Inc.
10.74
-2.89%
SRNE Sorrento Therapeutics, Inc.
0.0021
0.00%
KPRX Kiora Pharmaceuticals, Inc.
3.0200
-1.63%
CCCC C4 Therapeutics, Inc.
1.6800
+3.70%
TENX Tenax Therapeutics, Inc.
5.70
-3.89%
ATRA Atara Biotherapeutics, Inc.
8.82
+1.26%
9606.HK Duality Biotherapeutics, Inc.
273.400
-2.36%
IGMS IGM Biosciences, Inc.
1.2100
0.00%
MOLN Molecular Partners AG
3.8400
-1.54%
STOK Stoke Therapeutics, Inc.
11.53
-2.45%